FAQ · IFRA, reformulations, vintage

IFRA vs. EU Cosmetics Regulation: what is the difference?

IFRA Standards are industry self-regulation maintained by the International Fragrance Association. EU Cosmetics Regulation 1223/2009 is binding European law. They overlap but operate differently.

The essentials

The two frameworks governing fragrance ingredient safety in Europe operate on different legal logics. The IFRA Standards Library is industry self-regulation published by the International Fragrance Association, an industry body headquartered in Brussels (Belgium). Its standards set usage restrictions and prohibitions for individual fragrance materials, based on safety assessments produced by the Research Institute for Fragrance Materials. Compliance is not statutory but is contractually required by most ingredient suppliers and many retailers, which makes IFRA effectively binding across the industry (IFRA, accessed 2026-05-29).

The EU Cosmetics Regulation (EC) 1223/2009 is binding European Union law with direct effect in all 27 member states. It defines mandatory requirements for product safety assessment, ingredient restriction lists in its Annexes II, III, IV, V, and VI, mandatory allergen declaration on labels, and product notification through the Cosmetic Products Notification Portal. Non-compliance triggers product withdrawal, fines, and legal liability.

The two systems overlap rather than duplicate. IFRA Standards address ingredient-level safety on the perfumer's side of the supply chain; the EU Regulation addresses finished product safety and consumer information on the brand's side. A finished fragrance sold in the EU must satisfy both: it must use materials compliant with IFRA Standards and must comply with EU Regulation 1223/2009 for safety, labeling, and notification (European Commission, accessed 2026-05-29).

Scope and material coverage

IFRA publishes Standards on a specific list of fragrance materials evaluated by RIFM for safety. As of the 51st Amendment of 2023, the IFRA Code maintains hundreds of restriction and prohibition Standards covering individual materials and material families. Each Standard specifies maximum use levels per IFRA category of finished product, from category 1 (lip products) to category 12 (non-skin or incidental skin contact).

EU Regulation 1223/2009 covers all cosmetic ingredients, not only fragrance materials. Its Annex II lists prohibited substances, Annex III lists restricted substances with maximum concentrations, Annex IV lists permitted colorants, Annex V lists permitted preservatives, and Annex VI lists permitted UV filters. Fragrance-specific restrictions sit within Annex III, including the 26 fragrance allergens declared since 2003 and the 81 expanded allergens introduced by Regulation EU 2023/1545 (European Commission, Regulation EU 2023/1545).

How the two frameworks interact

The frameworks reinforce each other rather than conflict. RIFM safety dossiers underpin both IFRA Standards and the scientific opinions issued by the EU Scientific Committee on Consumer Safety, which in turn inform Commission decisions to update Regulation 1223/2009 Annexes. A material restricted under IFRA based on a RIFM assessment often appears in a subsequent Regulation 1223/2009 update, formalizing the restriction into binding EU law.

The sequence runs from scientific assessment (RIFM, SCCS), through industry self-regulation (IFRA Standards), into binding regulation (EU 1223/2009 amendments). Compliance with the latest IFRA Standard typically anticipates compliance with the next EU update on the same material, which is why fragrance suppliers track IFRA amendments closely even when the regulatory change has not yet been formalized.

Consequences for perfumers and brands

For a perfumer working with IFRA-certified suppliers, the IFRA constraint applies before the EU Regulation does. The supplier will not deliver a fragrance concentrate that violates IFRA Standards. The brand placing the finished product on the EU market is then responsible for ensuring labeling compliance, safety assessment under Article 10, product information file under Article 11, and notification through the CPNP portal.

For niche houses operating outside the major supplier contractual framework, IFRA compliance becomes a choice rather than a contractual obligation. Some artisan houses publicly position themselves against IFRA restrictions, though they remain subject to EU Regulation 1223/2009 when selling into the EU market. The distinction between voluntary IFRA non-compliance and unlawful EU regulatory breach is significant and not always made clearly in industry debate.

Outside the European Union

IFRA is global by design, with member national associations in roughly 20 countries including the United States (Fragrance Creators Association), Japan, and Brazil. Its Standards apply by contract wherever participating suppliers sell ingredients, regardless of jurisdiction. The United States lacks a single binding equivalent to EU Regulation 1223/2009; instead, the Federal Food, Drug, and Cosmetic Act sets a lighter framework, supplemented by the Modernization of Cosmetics Regulation Act of 2022 which introduced facility registration and ingredient reporting from December 2023.

The result is asymmetric regulation: a US-marketed fragrance must satisfy IFRA via supplier contracts but faces lighter statutory ingredient restrictions than an EU-marketed one. The same composition can be legal in the US and non-compliant with Regulation 1223/2009 if it uses materials banned in EU Annex II. Niche houses exporting from the US to the EU therefore reformulate selectively for EU distribution.

Sources

  • IFRA, IFRA Standards Library and Code of Practice, 51st Amendment. Accessed 2026-05-29.
  • European Commission, Regulation (EC) 1223/2009 on cosmetic products, consolidated text. Accessed 2026-05-29.
  • European Commission, Regulation EU 2023/1545 amending Regulation EC 1223/2009 (expanded fragrance allergens), 2023.
  • US FDA, Modernization of Cosmetics Regulation Act (MoCRA), 2022, implementation guidance. Accessed 2026-05-29.
Published 29 May 2026 · Updated 30 May 2026 · Last fact check: 30 May 2026 · Osmetheca · Editorial team